Wilson's Disease: Food Therapy out of Trace Elements

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2023 Jan 9

PMID 36619859

Authors

Wen-Jie Li

Huan-Ling Chen

Bin Wang

Lei Yao

Xiao-Ping Wang

Affiliations

Soon will be listed here.

Abstract

Hepatolenticular degeneration, also known as Wilson's disease (WD), is an autosomal recessive inheritance nervous disorder of copper metabolism. The treatment of hepatolenticular degeneration emphasizes the combination of medical therapy and dietary therapy, such as a high zinc, low copper and sulfhydryl rich diet. Food therapy of WD based on trace elements is presented in this paper.

Citing Articles

Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease.

Choi W, Cha S, Kim K Cells. 2024; 13(14.

PMID: 39056796 PMC: 11274827. DOI: 10.3390/cells13141214.

Single-cell RNA sequencing technology in human spermatogenesis: Progresses and perspectives.

Jia H, Wang W, Zhou Z, Chen Z, Lan Z, Bo H Mol Cell Biochem. 2023; 479(8):2017-2033.

PMID: 37659974 DOI: 10.1007/s11010-023-04840-x.

Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease.

Zhou X, Liao J, Liu Y, Qin H, Xiao X Brain Behav. 2023; 13(9):e3170.

PMID: 37491953 PMC: 10498091. DOI: 10.1002/brb3.3170.

Clinical and genetic characterization of pediatric patients with Wilson's disease from Yunnan province where ethnic minorities gather.

Wang Y, Fang J, Li B, Li C, Liu S, He J Front Genet. 2023; 14:1142968.

PMID: 37020998 PMC: 10067573. DOI: 10.3389/fgene.2023.1142968.

References

Choi H, Oh D, Kim M, Cai L, Lee J, Kim E . Copper deficiency affects the developmental competence of porcine oocytes matured . Front Cell Dev Biol. 2022; 10:993030. PMC: 9490373. DOI: 10.3389/fcell.2022.993030. View

Yang R . [Treatment of hepatolenticular degeneration with integrated Chinese and Western medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007; 27(9):773-5. View

Brewer G, Yuzbasiyan-Gurkan V . Wilson disease. Medicine (Baltimore). 1992; 71(3):139-64. DOI: 10.1097/00005792-199205000-00004. View

Nishito Y, Kambe T . Absorption Mechanisms of Iron, Copper, and Zinc: An Overview. J Nutr Sci Vitaminol (Tokyo). 2018; 64(1):1-7. DOI: 10.3177/jnsv.64.1. View

Wang B, Shen T, Mao L, Xie L, Fang Q, Wang X . Establishment of a Risk Prediction Model for Mild Cognitive Impairment among Elderly Chinese. J Nutr Health Aging. 2020; 24(3):255-261. DOI: 10.1007/s12603-020-1335-2. View

Jing X, Yuan X, Li G, Chen J, Wu R, Yang L . Increased Magnetic Susceptibility in the Deep Gray Matter Nuclei of Wilson's Disease: Have We Been Ignoring Atrophy?. Front Neurosci. 2022; 16:794375. PMC: 9198485. DOI: 10.3389/fnins.2022.794375. View

Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V . Wilson disease. Nat Rev Dis Primers. 2018; 4(1):21. PMC: 6416051. DOI: 10.1038/s41572-018-0018-3. View

Lee J, Dalton R, Dennison C . Copper delivery to an endospore coat protein of . Front Cell Dev Biol. 2022; 10:916114. PMC: 9484137. DOI: 10.3389/fcell.2022.916114. View

Palumbo C, Schilsky M . Clinical practice guidelines in Wilson disease. Ann Transl Med. 2019; 7(Suppl 2):S65. PMC: 6531645. DOI: 10.21037/atm.2018.12.53. View

10.

Taylor A, Tsuji J, Garry M, McArdle M, Goodfellow Jr W, Adams W . Critical Review of Exposure and Effects: Implications for Setting Regulatory Health Criteria for Ingested Copper. Environ Manage. 2019; 65(1):131-159. PMC: 6960211. DOI: 10.1007/s00267-019-01234-y. View

11.

Cai H, Cheng X, Wang X . ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease. Hepatology. 2022; 76(4):1046-1057. PMC: 9790736. DOI: 10.1002/hep.32484. View

12.

Einer C, Leitzinger C, Lichtmannegger J, Eberhagen C, Rieder T, Borchard S . A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats. Cell Mol Gastroenterol Hepatol. 2018; 7(3):571-596. PMC: 6407159. DOI: 10.1016/j.jcmgh.2018.12.005. View

13.

Li W, Chen C, You Z, Yang R, Wang X . Current Drug Managements of Wilson's Disease: From West to East. Curr Neuropharmacol. 2015; 14(4):322-5. PMC: 4876588. DOI: 10.2174/1570159x14666151130222427. View